Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

97.3K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The metabolic effects of glucocorticoid replacement therapy in patients with secondary adrenal insufficiency due to hypothalamic-pituitary diseases: results from a retrospective and longitudinal study.

Pituitary·2026
Same author

Incidentally discovered, intentionally managed: a narrative review of the last decade's updates on the management of neuroendocrine tumor of the appendix.

Annals of gastroenterology·2026
Same author

Clinical Exome Sequencing Study in a Cohort of Growth Hormone-Secreting Pituitary Adenomas.

Endocrine, metabolic & immune disorders drug targets·2026
Same author

A Four-Week Treatment With Dapagliflozin Is Associated With a Reduction in Insulin-Stimulated Renal Cortical Glucose Uptake: A Post Hoc Analysis From a Pilot Study.

Diabetes, obesity & metabolism·2026
Same author

Proteomic profile of bone in patients with acromegaly: new insights from a pilot exploratory study.

Journal of endocrinological investigation·2026
Same author

Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review.

Reviews in endocrine & metabolic disorders·2026

Related Experiment Video

Updated: Dec 25, 2025

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
08:46

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis

Published on: August 26, 2020

5.2K

Identification of two novel LDLR variants by Next Generation Sequencing.

Simona Moffa1, Giorgia Mazzuccato2, Maria De Bonis2

  • 1Endocrinologia e Diabetologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy - Istituto Patologia Speciale Medica, Università Cattolica del Sacro Cuore, Rome, Italy.

Annali Dell'Istituto Superiore Di Sanita
|April 4, 2020
PubMed
Summary

Next Generation Sequencing (NGS) identified two novel low-density lipoprotein receptor (LDLR) variants in familial hypercholesterolemia (FH) patients, enabling definitive diagnosis and treatment planning.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.6K

Related Experiment Videos

Last Updated: Dec 25, 2025

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
08:46

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis

Published on: August 26, 2020

5.2K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

34.5K
Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.6K

Area of Science:

  • Genetics
  • Molecular Biology
  • Cardiovascular Disease

Background:

  • Familial hypercholesterolemia (FH) is an autosomal dominant disorder causing elevated LDL-C.
  • Targeted Next Generation Sequencing (NGS) offers a powerful approach to identify genetic variants associated with FH.
  • Expanding the spectrum of pathogenic variants (PVs) is crucial for FH diagnosis.

Observation:

  • Two patients, a 48-year-old Asian woman and a 46-year-old Caucasian man, presented with hypercholesterolemia.
  • The Caucasian man had a history of childhood hypercholesterolemia.

Findings:

  • An effective NGS pipeline (FH-Devyser kit/Amplicon Suite) was employed for variant detection.
  • No known pathogenic variants were found in common FH-associated genes (LDLR, APOB, APOE, LDLRAP1, STAP1, PCSK9).
  • Two novel LDLR variants (c.1564A>T, p.Ile522Phe and c.1688C>T, p.Pro563Leu) were identified.

Implications:

  • The NGS pipeline facilitated a definitive FH diagnosis for both families.
  • Early diagnosis enables timely therapeutic interventions for FH patients.
  • In silico analysis suggests the novel LDLR variants are likely deleterious, warranting further in vitro functional assessment.